| IEX |
Report |
Revenue |
IN-LINE |
pred ~$910M vs. cons $905.4M |
MEDIUM |
| IEX |
Report |
Operating EPS |
BEAT |
pred ~$1.80 vs. cons $1.773 |
MEDIUM |
| IEX |
Report |
Organic orders growth |
BEAT |
pred ~8.0% vs. cons 7.7% |
MEDIUM |
| IEX |
Guide |
FY26 organic growth (FY26) |
UNCHANGED |
guide 3%–4% vs. cons UNVERIFIED |
LOW |
| IEX |
Guide |
FY26 adjusted EPS (FY26) |
UNCHANGED |
guide $8.35–$8.55 vs. cons UNVERIFIED |
LOW |
| IEX |
Guide |
HST / backlog commentary (2H26) |
BETTER |
guide continued strong HST/backlog tone vs. cons UNVERIFIED |
MEDIUM |
| IEX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.5% |
— |
LOW |
| IEX |
Return |
5-day cumulative residual |
+2.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest estimate support, no multiple re-rate |
LOW |